Epinephrine

Generic Name
Epinephrine
Brand Names
Adrenalin, Allerject, Anapen, Articadent, Astracaine, Auvi-Q, Citanest, Citanest Forte, Emerade, Epipen, Lignospan, Marcaine, Marcaine With Epinephrine, Octocaine, Octocaine With Epinephrine, Orabloc, Scandonest, Sensorcaine, Sensorcaine With Epinephrine, Septanest, Septocaine, Symjepi, Ultacan, Ultracaine, Vivacaine, Xylocaine, Xylocaine With Epinephrine, Zorcaine, Eurneffy
Drug Type
Small Molecule
Chemical Formula
C9H13NO3
CAS Number
51-43-4
Unique Ingredient Identifier
YKH834O4BH
Background

Epinephrine, also known as adrenaline, is a hormone and neurotransmitter and produced by the adrenal glands that can also be used as a drug due to its various important functions. Though it has long been used in the treatment of hypersensitivity reactions, epinephrine in the auto-injector form (EpiPen) has been available since 1987 in the USA. Many new products/biosimilars and dosage routes have been approved under various names over the last several decades , , . On August 16, 2018, Teva Pharmaceuticals USA gained approval to market its generic epinephrine auto-injector in 0.3 mg and 0.15 mg strengths . Dosage delivery routes for epinephrine include intravenous, inhalation, nebulization, intramuscular injection, and subcutaneous injection.

In general, the most common uses of parenteral epinephrine are to relieve respiratory distress due to bronchospasm, to provide rapid relief of hypersensitivity (anaphylactic or anaphylactoid) reactions to drugs, animal serums and other allergens, and to prolong the action of infiltration anesthetics . In addition to the above functions, epinephrine is the primary drug administered during cardiopulmonary resuscitation (CPR) to reverse cardiac arrest , . It can be used in severe cases of croup .

Indication

Epinephrine injection is indicated in the emergency treatment of type I allergic reactions, including anaphylaxis. It is also used to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

Epinephrine's cardiac effects may be of use in restoring cardiac rhythm in cardiac arrest due to various causes but is not used in cardiac failure or in hemorrhagic, traumatic, or cardiogenic shock .

Epinephrine is used as a hemostatic agent. It is also used in treating mucosal congestion of hay fever, rhinitis, and acute sinusitis; to relieve bronchial asthmatic paroxysms; in syncope due to complete heart block or carotid sinus hypersensitivity; for symptomatic relief of serum sickness, urticaria, angioneurotic edema; for resuscitation in cardiac arrest following anesthetic accidents; in simple (open angle) glaucoma; for relaxation of uterine musculature and to inhibit uterine contractions. Epinephrine injection can be utilized to prolong the action of local anesthetics .

In addition to the above, epinephrine is used as an over the counter (OTC) agent for the intermittent symptoms of asthma, such as wheezing, tightness of chest and shortness of breath . It is also used for the maintenance of mydriasis during intraocular surgery .

Associated Conditions
Anaphylaxis, Angioneurotic Edema, Bleeding, Bronchospasm, Complete Heart Block, Hypotension, Idiopathic Anaphylaxis, Laryngotracheobronchitis, Mild Intermittent Asthma, Nasal Congestion, Open Angle Glaucoma (OAG), Respiratory Distress, Severe Asthma, Syncope, Type I Hypersensitivity, Urticaria, Uterine Contractions, Ventricular Fibrillation, Resuscitation in cardiac arrest following anesthetic accidents, Severe hypersensitivity reactions, Unresponsive Asystole, Unresponsive Bradycardia
Associated Therapies
-

Study of Multistep Pharmacological and Invasive Management for Cardiogenic Shock

Phase 2
Completed
Conditions
Interventions
First Posted Date
2015-10-30
Last Posted Date
2021-07-26
Lead Sponsor
Niguarda Hospital
Target Recruit Count
24
Registration Number
NCT02591771
Locations
🇮🇹

Niguarda Hospital, Milan, MI, Italy

🇮🇹

Ospedale San Raffaele, Milano, Italy

Nebulized Adrenalin and Oral Betamethasone in Children With Bronchiolitis Attending Pediatric Emergencies.

First Posted Date
2015-10-27
Last Posted Date
2017-09-12
Lead Sponsor
Assistance Publique - Hôpitaux de Paris
Target Recruit Count
195
Registration Number
NCT02586961
Locations
🇫🇷

AP-HP, Antoine Béclère Hospital, Clamart, France

Effect of Local Infiltration Anesthesia With Ropivacaine on Postoperative Pain After Hip Hemiarthroplasty

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2015-10-23
Last Posted Date
2020-09-11
Lead Sponsor
St. Olavs Hospital
Target Recruit Count
123
Registration Number
NCT02585011
Locations
🇳🇴

Ortopedisk forskningssenter, St.Olavs Hospital, Trondheim, Norway

Postoperative Pain Control After Periarticular Injection During Total Knee Arthroplasty

First Posted Date
2015-10-07
Last Posted Date
2022-03-04
Lead Sponsor
Virginia Commonwealth University
Target Recruit Count
64
Registration Number
NCT02570503
Locations
🇺🇸

Virginia Commonwealth University, Richmond, Virginia, United States

Evaluation of Motor Sparing Knee Block to Infiltration Analgesia for Pain Following Knee Arthroplasty

First Posted Date
2015-09-03
Last Posted Date
2016-11-15
Lead Sponsor
Lawson Health Research Institute
Target Recruit Count
135
Registration Number
NCT02540070
Locations
🇨🇦

University Hospital, London Health Sciences Centre, London, Ontario, Canada

Trial of Hemospray Plus Epinephrine Injection Versus Endoscopic Hemoclip

First Posted Date
2015-09-01
Last Posted Date
2015-09-01
Lead Sponsor
University of Sao Paulo General Hospital
Target Recruit Count
40
Registration Number
NCT02537353

Protracted Mixture of Local Anesthetics for Major Foot and Ankle Surgery

First Posted Date
2015-08-18
Last Posted Date
2016-09-23
Lead Sponsor
Rasmus Wulff Hauritz
Target Recruit Count
56
Registration Number
NCT02526199
Locations
🇩🇰

Department of Anesthesia, Aarhus University Hospital, Aarhus, Region Midt, Denmark

TAP vs Surgical Infiltration of Local Anesthetic in Laparoscopic and Robotic Hysterectomy

First Posted Date
2015-08-10
Last Posted Date
2019-02-08
Lead Sponsor
University of Minnesota
Target Recruit Count
87
Registration Number
NCT02519023
Locations
🇺🇸

University of Minnesota, Minneapolis, Minnesota, United States

© Copyright 2024. All Rights Reserved by MedPath